We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+2.85%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$14.8B
AUM Growth
+$2.92B
(+25%)
Cap. Flow
+$3.28B
Cap. Flow
% of AUM
22.14%
Top 10 Holdings %
Top 10 Hldgs %
12.56%
Holding
1,029
New
443
Increased
269
Reduced
185
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$217M |
| 2 |
Apple
AAPL
|
+$208M |
| 3 |
Microsoft
MSFT
|
+$199M |
| 4 |
Amazon
AMZN
|
+$136M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$125M |
| 2 |
Gilead Sciences
GILD
|
+$107M |
| 3 |
PR
Permian Resources
PR
|
+$85.4M |
| 4 |
Reddit
RDDT
|
+$84.1M |
| 5 |
Keysight
KEYS
|
+$79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.96% |
| 2 | Technology | 25.64% |
| 3 | Financials | 7.58% |
| 4 | Industrials | 6.88% |
| 5 | Communication Services | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NARI
126
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $36.4M | 0.25% |
+712,910
| New | +$35M |
|
127
Warrior Met Coal
HCC
$4.34B
| $36.4M | 0.25% |
670,380
+463,577
| +224% | +$29.6M |
|
|
128
Keysight
KEYS
$57.3B
| $35.8M | 0.24% |
222,645
-489,943
| -69% | -$79M |
|
129
Walt Disney
DIS
$171B
| $35.5M | 0.24% |
319,066
+21,628
| +7% | +$2.27M |
|
|
ANSS
130
DELISTED
Ansys
ANSS
| $35.5M | 0.24% |
105,251
+9,230
| +10% | +$3.09M |
|
131
Flex
FLEX
$46.1B
| $35.1M | 0.24% |
+914,841
| New | +$33.9M |
|
132
Pfizer
PFE
$142B
| $35M | 0.24% |
1,318,490
+191,957
| +17% | +$5.21M |
|
133
Viavi Solutions
VIAV
$9.85B
| $34.7M | 0.23% |
3,435,678
+2,779,615
| +424% | +$27.4M |
|
134
Krystal Biotech
KRYS
$9.47B
| $34.6M | 0.23% |
221,102
+41,287
| +23% | +$7.32M |
|
135
Axsome Therapeutics
AXSM
$10.9B
| $34.6M | 0.23% |
408,441
+109,872
| +37% | +$10.1M |
|
136
Zevra Therapeutics
ZVRA
$607M
| $34.5M | 0.23% |
4,139,593
+90,940
| +2% | +$776K |
|
|
B
137
DELISTED
Barnes Group Inc.
B
| $34.5M | 0.23% |
729,097
+518,146
| +246% | +$24.1M |
|
138
Expedia Group
EXPE
$36.2B
| $34.4M | 0.23% |
+184,397
| New | +$31.8M |
|
139
Comcast
CMCSA
$87.4B
| $34M | 0.23% |
905,314
+189,759
| +27% | +$7.88M |
|
140
Assurant
AIZ
$13.9B
| $33.5M | 0.23% |
157,140
-72,270
| -32% | -$15M |
|
141
Intel
INTC
$499B
| $33.2M | 0.22% |
1,657,825
+1,403,912
| +553% | +$31.6M |
|
142
Exelixis
EXEL
$14.1B
| $33.1M | 0.22% |
994,532
+1,402
| +0.1% | +$45.5K |
|
143
Infosys
INFY
$49.7B
| $33.1M | 0.22% |
+1,508,675
| New | +$33.8M |
|
144
Visa
V
$687B
| $32.9M | 0.22% |
104,097
+103,313
| +13,178% | +$31.1M |
|
145
Leidos
LDOS
$16.1B
| $32.7M | 0.22% |
227,286
-88,065
| -28% | -$14.7M |
|
|
ALTR
146
DELISTED
Altair Engineering Inc
ALTR
| $32.7M | 0.22% |
+299,998
| New | +$30.9M |
|
147
Labcorp
LH
$24.7B
| $32.6M | 0.22% |
141,995
+21,734
| +18% | +$4.99M |
|
148
Stryker
SYK
$128B
| $32.3M | 0.22% |
89,806
-91,497
| -50% | -$33.9M |
|
149
Freshpet
FRPT
$3.02B
| $32.1M | 0.22% |
216,971
-108,725
| -33% | -$15.8M |
|
150
Fox Class A
FOXA
$24.6B
| $31.8M | 0.21% |
653,889
+14,536
| +2% | +$655K |
|
Similar funds
PAM
TCIIS
UIM
VAI
Woodline Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Woodline Partners held 1,029 positions worth $14.8B, up 25% from $11.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Woodline Partners deployed $3.28B of net new capital in Q4 2024, opening 443 new positions and adding to 269 existing holdings. Its largest new stake was TE Connectivity: 890,754 shares worth $127M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 43% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $107M trimmed.
- Woodline Partners's largest Q4 2024 buy was TE Connectivity: 890,754 shares worth $127M.
- Woodline Partners added most to NVIDIA in Q4 2024, an estimated $217M increase.
- Woodline Partners's biggest Q4 2024 reduction was Gilead Sciences, cutting an estimated $107M.
- Woodline Partners fully exited ASML in Q4 2024, selling an estimated $125M.
- Woodline Partners's ten largest holdings make up 13% of its $14.8B portfolio in Q4 2024.
- Woodline Partners opened 443 new positions and closed 112 in Q4 2024.
- Woodline Partners's portfolio value rose 25% quarter-over-quarter to $14.8B.
Based on Woodline Partners's 13F filing for Q4 2024, filed 14 Feb 2025.